LIfT Biosciences (NASDAQ: LIFT) Forms Scientific Advisory Board to Propel Cancer Therapy Development
Market Overview LIfT Biosciences (NASDAQ: LIFT) is advancing its market position with the creation of a Scientific Advisory Board aimed at accelerating its cancer therapy pipeline. Focused on innovative immuno-modulatory neutrophil-based treatments, LIfT Biosciences operates within the dynamic biotechnology sector, which continues to attract significant investor interest due to promising advances in oncology. The company’s shares have gained market attention as investors anticipate progress in LIfT Biosciences’ lead program targeting…
